Armin Szegedi, MD PhD

Examiner
DISC Type : cs

Chief Medical Officer at Sumitomo Pharma America, Inc.

Rahway, New Jersey, United States

Overview

Armin Szegedi is the Chief Medical Officer at Sumitomo Pharma America, where he leverages his extensive experience in drug development. His expertise covers a broad range of disorders in psychiatry, neurology, pain, and anesthesia, built upon a foundation from his MD at Johannes Gutenberg University Mainz and leadership roles at Merck and Allergan.

He is a vocal advocate for advancing treatments for serious mental health conditions and has championed women in leadership roles. He frequently highlights team collaborations and their shared commitment to patients, particularly through partnerships with companies like Otsuka Pharmaceutical.

Unique fact: He has authored or co-authored more than 100 publications in peer-reviewed scientific journals.

Personality Overview

Late Adopter

Unexpressive

Status Quo Seeker

They do not like taking risks at all and go for proven options in the end.  They are heavily focused on quality and prefer doing things the right way, even if it takes time. They are always well-planned and adopt a systematic approach.

Topics They Care About

CNS Drug Development
His career is dedicated to clinical development for psychiatry and neurology, having led CNS therapeutic areas at major pharmaceutical companies like Allergan and Merck.
Mental Health Advocacy
Frequently posts about advancing innovative treatments for conditions like bipolar disorder and working to eliminate the stigmas surrounding mental health.
Pharmaceutical Collaboration
He emphasizes the importance of partnerships, such as the collaboration with Otsuka, to successfully advance novel compounds and treatments to patients.

Media Appearances

Armin has no verified media appearances

Work History

7-2023 - 3-2024
Chief Medical Officer at Sumitomo Pharma America, Inc.
7-2020 - 6-2023
Senior Vice President and Chief Medical Officer at Sunovion Pharmaceuticals
3-2014 - 7-2020
Vice President Clinical Development CNS at Allergan
8-2012 - 12-2013
Executive Director Clinical Research at Merck
12-2009 - 8-2012
Section Head Psychiatry, Clinical Neurosciences; Clinical Lead Sugammadex (Bridion) at Merck

Education

1985 - 2003
MD from Johannes Gutenberg University Mainz
Education details unavailable from Friedrich Woehler Gymnasium Singen

More Information

Social Presence :

Prographics :

Exp : 22 Location : Rahway, New Jersey, United States Job Level : N/A Designation : Chief Medical Officer at Sumitomo Pharma America, Inc.
URL has been copied!

Insights For Selling To Armin

During A Call Or A Meeting

DO's

  • Be firm in your communication and stay in control
  • Ask them which other stakeholders would be important for this purchase decision
  • Expect them to be slow and cautious, encourage them to ask more questions

DONT's

  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't rely on relationship building even if they act pleasantly
  • Don't push them too hard to make fast decisions, give them time

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Armin is

  • Proof of usage by others in the industry, case studies showing ROI are likely to work the best with them.
  • Will you ever get a clear answer from Armin

  • Often, they don't say no, or keep going about it in circles.

Insights For Deal Planning

    How fast (or slow) will Armin move?

  • They are some of the slowest movers and take their time reaching decisions.
  • Can Armin take some risk or not?

  • They have very low acceptance of risk even if they do not say it directly.

You And Armin

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.